Similar articles

• [Myasthenia gravis; clinical aspects, pathophysiology and treatment].

  Oosterhuis HJ. Oosterhuis HJ. Ned Tijdschr Geneeskd. 1983 Sep 24;127(39):1765-71. Ned Tijdschr Geneeskd. 1983. PMID: 6314161 Review. Dutch. No abstract available.
• Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.

  Saulat B, Maertens P, Hamilton WJ, Bassam BA. Saulat B, et al. Neurology. 2007 Aug 21;69(8):803-4. doi: 10.1212/01.wnl.0000267694.45244.f4. Neurology. 2007. PMID: 17709714 No abstract available.
• Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.

  Jordan B, Schilling S, Zierz S. Jordan B, et al. J Neurol. 2016 Jan;263(1):174-6. doi: 10.1007/s00415-015-7982-2. Epub 2015 Dec 8. J Neurol. 2016. PMID: 26645394 No abstract available.
• [Myasthenia gravis].

  Tanaka K. Tanaka K. Nihon Rinsho. 2004 May;62 Suppl 5:580-5. Nihon Rinsho. 2004. PMID: 15197988 Review. Japanese. No abstract available.
• Ocular myasthenia gravis.

  Gilbert ME, Savino PJ. Gilbert ME, et al. Int Ophthalmol Clin. 2007 Fall;47(4):93-103, ix. doi: 10.1097/IIO.0b013e31815726f5. Int Ophthalmol Clin. 2007. PMID: 18049283 Review. No abstract available.